Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of HP-3150 (diclofenac patch) in Patients with Low Back Pain
jRCT2080225012Phase 3Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of diclofenac in lumbodynia (LBP), sponsored by Hisamitsu Pharmaceutical Co., Inc. Primary endpoint: Pain VAS score improvement and persistence. Started Jan 2020; status: completed.
02
Drugs
diclofenac
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on jRCT2080225012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225012.